ALPS Advisors’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-60,180
| Closed | -$3.82M | – | 1060 |
|
|
2025
Q1 | $3.82M | Sell |
60,180
-5,993
| -9% | -$380K | 0.02% | 264 |
|
|
2024
Q4 | $3.07M | Buy |
66,173
+3,595
| +6% | +$167K | 0.02% | 284 |
|
|
2024
Q3 | $1.8M | Sell |
62,578
-660
| -1% | -$19K | 0.01% | 379 |
|
|
2024
Q2 | $914K | Buy |
63,238
+6,236
| +11% | +$90.2K | 0.01% | 484 |
|
|
2024
Q1 | $917K | Buy |
57,002
+2,954
| +5% | +$47.5K | 0.01% | 506 |
|
|
2023
Q4 | $1.07M | Sell |
54,048
-4,563
| -8% | -$90.7K | 0.01% | 459 |
|
|
2023
Q3 | $955K | Buy |
58,611
+207
| +0.4% | +$3.37K | 0.01% | 466 |
|
|
2023
Q2 | $1.23M | Buy |
58,404
+8,477
| +17% | +$179K | 0.01% | 419 |
|
|
2023
Q1 | $1M | Buy |
49,927
+463
| +0.9% | +$9.3K | 0.01% | 470 |
|
|
2022
Q4 | $1.29M | Buy |
+49,464
| New | +$1.29M | 0.01% | 394 |
|